Related Experiment Video
Updated: Jul 14, 2026

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
Codon usage bias in Chlamydia trachomatis and the effect of codon modification in the MOMP gene on immune responses
Yan Zheng1, Wei-Ming Zhao, Hong Wang
1Department of Medical Microbiology, School of Medicine, Shandong University, Jinan, Shandong 250012, PR China.
Abstract:
Chlamydia trachomatis is a kind of obligate intracellular bacterial pathogen that causes ocular and sexually transmitted diseases. In this study, we analyzed the codon usage patterns of the C. trachomatis mouse pneumonitis biovar (MoPn) and Homo sapiens. We found large differences between MoPn and human codon usages. To enhance the expression of Chlamydia protein in mammalian cells, the DNA sequence encoding the major outer-membrane protein (MOMP) of MoPn was modified to substitute the human-preferred codons for rarely used codons. The huma-optimized MOMP gene was synthesized and cloned into the pcDNA3 vector, as was the wild-type MOMP gene. The protein expression levels of the human-optimized MOMP and wild-type MOMP genes were compared. The experiments showed that the human-optimized MOMP gene produced significantly higher levels of MOMP protein than the wild-type MOMP, both in vitro and in vivo, but no obvious difference was observed in the levels of modified and native MOMP mRNA expression. The immunogenicity of the 2 constructs was examined using BALB/c mice following intramuscular immunization. The results showed that the mice immunized with the human-optimized MOMP produced higher levels of antigen-specific IgG antibody and showed stronger delayed-type hypersensitivity reactions and proliferative T cell responses than those immunized with the wild-type MOMP. Antigen-specific stimulation of spleen cells obtained from human MOMP DNA immunized mice produced higher levels of interferon-gamma than those obtained from wild-type MOMP DNA immunized mice. Taken together, the data show that human-optimized codon optimization can significantly enhance the gene expression and immunogenicity of the C. trachomatis MOMP DNA vaccine.
Insights
Human codon optimization of Chlamydia trachomatis major outer-membrane protein (MOMP) significantly boosts protein expression and immune responses. This enhances the potential of C. trachomatis MOMP DNA vaccines in mammalian systems.
Area of Science:
- Microbiology
- Immunology
- Molecular Biology
Background:
- Chlamydia trachomatis is an obligate intracellular bacterium causing significant ocular and sexually transmitted infections.
- Significant differences exist in codon usage patterns between C. trachomatis mouse pneumonitis biovar (MoPn) and Homo sapiens.
- Enhancing Chlamydia protein expression in mammalian cells is crucial for vaccine development.
Purpose of the Study:
- To investigate the effect of human codon optimization on the expression and immunogenicity of the C. trachomatis MoPn major outer-membrane protein (MOMP).
- To compare the efficacy of a human codon-optimized MOMP DNA vaccine with the wild-type counterpart.
Main Methods:
- DNA sequences encoding MoPn MOMP were modified using human-preferred codons.
- Synthesized human-optimized and wild-type MOMP genes were cloned into expression vectors.
- Protein expression levels, mRNA expression, and immunogenicity (antibody production, cellular responses) were assessed in vitro and in vivo using mouse models.
Main Results:
- Human codon optimization led to significantly higher MOMP protein levels in mammalian cells, without altering mRNA levels.
- Mice immunized with the human-optimized MOMP DNA vaccine exhibited enhanced antigen-specific IgG antibody production.
- Stronger delayed-type hypersensitivity reactions, increased T cell proliferation, and higher interferon-gamma production were observed in mice immunized with the optimized construct.
Conclusions:
- Human codon optimization is an effective strategy to enhance gene expression of C. trachomatis MOMP in mammalian systems.
- Optimized MOMP DNA vaccination significantly improves immunogenicity, suggesting potential for more effective Chlamydia vaccines.
- Codon optimization represents a promising approach for developing improved DNA vaccines against Chlamydia infections.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Leaky Scanning
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Mutations in Microorganisms
Bacterial Phylum Chlamydiae

